MAIA Biotechnology, Inc. (MAIA) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 49.14M |
| Enterprise Value | -8.61B |
| P/E Ratio | -1.8 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.95 |
| Return On Equity | -2.11 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -22.4M |
| Net Income | -22.4M |
| Diluted EPS | -0.7 |
Balance Sheet
| Total Cash | 27.6M |
| Total Cash/Share | 0.45 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.51 |
| Book Value Per Share | 0.34 |
Price History
| 52-Week Change | -21.92 |
| 52-Week High | 3.19 |
| 52-Week Low | 0.87 |
| Moving Average 50 Days | 1.27 |
| Moving Average 200 Days | 1.47 |
Statistics
| Average Volume | 474,759 |
| Shares Outstanding | 61.74M |
| % Held by Institutions | 22.25 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
